Drug Discovery Article Competition

Do you want to be published? Be in with a chance to have your work published in Drug Target Review and showcased at ELRIG Drug Discovery 2023!

In partnership with:

ELRIG logo

     Competition deadline:
     30 June 2023, 3:00 PM BST                 

    

The Drug Discovery Article Competition is an exciting opportunity for you to showcase your work. Submit your research paper, article or opinion piece for a chance to be recognized and published in in Drug Target Review’s Autumn journal. What’s more, your work will be recognised at this year’s ELRIG Drug Discovery annual conference (18-19 October; ACC Liverpool Exhibition Centre, UK).

 ENTER NOW 

 

 

WHY ENTER?

  • Your research published in Drug Target Review, reaching a community of more than 125,000 scientists
  • Your research recognised at ELRIG Drug Discovery annual conference
  • Complimentary onsite accommodation
  • Subsidised travel to the conference
  • FREE registration to ELRIG Drug Discovery – your chance to learn and network with industry peers
  • FREE subscription to Drug Target Review, giving you access to breaking news, thought leadership and expert insight


COMPETITION GUIDELINES

1. Select the conference theme that best aligns with your article.

2. Upload details of your research following the criteria below.

3. Your submission will be reviewed by a panel of industry experts and a winner will be chosen for each theme.

4. The Grand Prix article will be selected from the theme winners and will be published in Drug Target Review, Issue 3 on 14 September.

5. The Grand Prix author will be recognised on stage at ELRIG Drug Discovery on Thursday 19 October..


MAKE YOUR SUBMISSION

    *Required field

    Your details








    Your article

    To include:

    1. Headline / article title (max. 10 words)

    2. Introduction paragraph (max. 70 words)

    3. Full article (1,000 – 1,500 words)

    4. Vancouver referencing







    Competition T&Cs

    Winners will be notified via email on 10 August.

    By clicking register, you consent to Drug Target Review's terms and conditions and privacy policy. Your information will be processed in accordance with GDPR and you can unsubscribe at any time.

    Confirm that you're human